Moderna Stock News

Moderna (MRNA) said the Therapeutic Goods Administration ((TGA)) in Australia granted provisional registration for the use of mRNA COVID-19 vaccine Spikevax, in a 50 µg dose,…

CAPE TOWN/CHICAGO — Moderna Inc has applied for patents in South Africa relating to its COVID-19 vaccine, prompting fears the company could eventually seek to prevent a new African vaccine manufacturing hub from making its own version of the mRNA shot. Moderna spokesperson Colleen Hussey confirmed it had filed for patents “related to both the […]

Moderna (MRNA) plans to expand its commercial network in six additional countries in Europe.Moderna aims to set up a commercial presence in Belgium, Denmark, Norway, the…

Moderna''s (MRNA) Omicron-specific booster shot could be ready by August, Reuters reported citing company CEO Stéphane Bancel.However, the company is still collecting data to know if…

Australia’s medical regulator, the Therapeutic Goods Administration (TGA), said on Thursday that it has provisionally approved the Moderna COVID-19 vaccine for use in individuals aged six years and older. The decision follows the provisional approvals granted by the TGA to Moderna for the use of the vaccine, SPIKEVAX, in individuals aged 12 years and older… Read More

Moderna Inc., the US biotech company and maker of the popular mRNA covid vaccine, announced on Tuesday its plan to set up four subsidiaries in Singapore, Malaysia, Hong Kong and Taiwan to support the delivery of its vaccines across East and Southeast Asia. The Taiwan-based subsidiary is expected to be established by year’s end, and would bolster the existing medical community through recruitment of local talent and partnerships with hospitals. In a statement, Modern said its contract with Taiwan would see 200 million of its Covid-19 doses delivered this year, with another 15 million does arriving in 2023. In Taiwan, […] The story Moderna to set up subsidiaries in Taiwan, Hong Kong and SE Asia to dispense mRNA vaccines as seen on Thaiger News .

Europe News: BRUSSELS: An Omicron-specific booster could be ready by August, the CEO of US biotech firm Moderna told Reuters, but the firm is still gathering clini.

Moderna chief executive Stephane Bancel said in an interview the company aimed to have a booster ready by August 2022, before next autumn when he said more vulnerable people may need it

Moderna has become the second Covid vaccine approved for children aged six to 11 in Australia following Pfizer. Moderna was previously only been available to people 12 and over.

[International] : U.S. pharmaceutical company Moderna''s CEO Stéphane Bancel suggested on Wednesday that the end of the COVID-19 pandemic is approaching. Appearing on CNBC, the CEO said it is a "reasonable scenario" when asked if the pandemic was in its final stages. Bancel said he thinks there was about an 80 … [more...]

Fresh cases remained around 30,000 while more than 300 people died because of Covid or related complications on Wednesday. Among states, Kerala continues to lead and even Wednesday’s tally of 12,223 fresh infections accounted for around 40% of the country’s total caseload. Stay with TOI for latest updates:

"COVID Exhaustion": People Are "Done Being Told What To Do": Former CBOE Floor Trader Submitted by QTR''s Fringe Finance This is part 2 of an exclusive Fringe Finance interview with former floor trader Ryan Sellers (@OpenOutcrier), where we discuss options trading, trading vs. investing, his outlook on the markets, how the nation and the Fed will navigate 2022 and the state of overall liquidity. Ryan began trading in 2002 on the floor of the Chicago Board of Options Exchange (CBOE) as a market maker in the DJX and SPX pits. In 2005, he joined the proprietary trading firm Trebuchet Financial, where he continued to trade options and equities. In 2014, he began using the @OpenOutcrier Twitter handle to post real-time stock and options trading headlines, breaking news, rumors and strategy. In early 2017, http://openoutcrier.com/ was launched as an extension of the Twitter handle and integrated news platform. The site consists of the OOC Feed, a custom BenzingaPro newswire, chat room, curated social media feed, and searchable archive.

Spain''s Laboratorios Farmaceuticos Rovi SA has agreed on a 10-year extension to its deal with Moderna Inc (NASDAQ: MRNA ) to manufacture future drugs developed with the mRNA technology used for its COVID-19 shot. The new agreement includes a series of investments expected to increase manufacturing capacity across ROVI''s facilities in Madrid, Spain. The companies did … Full story available on Benzinga.com

This article was originally published on TipRanks.com Moderna, Inc. The post Moderna Expands Presence in Asia-Pacific with Four New Subsidiaries appeared first on Smarter Analyst .

Moderna''s CEO thinks the pandemic may be entering its final stages, but other health officials warn that it is too early to make that prediction.